| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.6M | -14.6% |
| R&D Expense | $44.2M | -12.4% |
| SG&A Expense | $26.9M | -12.6% |
| Operating Income | -$97.5M | +62.3% |
| Pre-tax Income | -$132.2M | +53.2% |
| Income Tax | $29K | +0.0% |
| Net Income | -$127.1M | +49.4% |
| EPS (Basic) | -$2.78 | +74.3% |
| EPS (Diluted) | -$2.78 | +74.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.9M | -31.2% |
| Accounts Receivable | $503K | -51.7% |
| Current Assets | $12.1M | -28.8% |
| Total Assets | $305.0M | -12.9% |
| Current Liabilities | $16.9M | -15.2% |
| Long-term Debt | $528K | -20.2% |
| Total Liabilities | $283.2M | +12.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$50.6M | +12.8% |
| Capital Expenditures | $578K | -28.5% |
| Investing Cash Flow | -$578K | +28.5% |
| Financing Cash Flow | $46.6M | +14.9% |
| Free Cash Flow | -$51.2M | +13.1% |
| $21.8M |
| -76.3% |